All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-0120ZP2683 | Anti-CEACAM8 (Besilesomab) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | Besilesomab | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2684 | Anti-CEACAM8 (Besilesomab) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | Besilesomab | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2685 | Anti-CEACAM8 (DS652AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS652AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2686 | Anti-CEACAM8 (DS652AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | DS652AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2687 | Anti-CEACAM8 (DS651AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS651AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP2688 | Anti-CEACAM8 (DS651AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | DS651AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
XS-0622-ZP3247 | Anti-CEACAM8 h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0622-ZP3419 | Anti-CEACAM8 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0822-YF270 | Anti-Human CEACAM8 (XW-270) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-270 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF271 | Anti-Human CEACAM8 (XW-271) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-271 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF272 | Anti-Human CEACAM8 (XW-272) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-272 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF273 | Anti-Mouse CEACAM8 (XW-273) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-273 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1190 | Anti-Human CEACAM8 (XW-270) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-270 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1191 | Anti-Human CEACAM8 (XW-271) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-271 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1192 | Anti-Human CEACAM8 (XW-272) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-272 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1193 | Anti-Mouse CEACAM8 (XW-273) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-273 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2110 | Anti-Human CEACAM8 (XW-270) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-270 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2111 | Anti-Human CEACAM8 (XW-271) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-271 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2112 | Anti-Human CEACAM8 (XW-272) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-272 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2113 | Anti-Mouse CEACAM8 (XW-273) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-273 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION